FDA: Baxter, Salix should revise warning labels

03/23/2008 | Chicago Tribune (tiered subscription model) · Yahoo!

The FDA on Friday recommended new warnings for pediatric use of Suprane, Baxter International's inhaled anesthetic, and Colazal, Salix Pharmaceuticals Ltd.'s anti-inflammatory drug. The agency said Suprane should address cardiac arrest risk following three reported cases among children, while Colazal should have warnings on heart and lung risks that other drugs in the same class carry.

View Full Article in:

Chicago Tribune (tiered subscription model) · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park